sufentanil has been researched along with Injury, Myocardial Reperfusion in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hou, Z; Lin, J; Qiu, L; Sun, L; Zhong, G | 1 |
| Bai, Y; Shang, Y; Shen, T; Wang, H; Wu, Q; Wu, Y | 1 |
| Esen, H; Onoglu, R; Sarkilar, G; Tire, Y; Uzun, ST | 1 |
| Bai, J; Jing, G; Liu, X; Yuan, H | 1 |
| Cao, Y; Cheng, X; Gu, E; Liu, X; Zhang, L; Zuo, Y | 1 |
| Chen, J; Gu, E; Zhang, L; Zhang, Y; Zhao, X; Zhu, B | 1 |
| Fang, WP; Gu, EW; Liu, XQ; Wu, Y; Zhang, L; Zhu, Y | 1 |
| Ma, H; Shen, T; Wang, JK; Wu, QL | 1 |
1 trial(s) available for sufentanil and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Effect of aortic root infusion of sufentanil on ischemia-reperfusion injury in patients undergoing mitral valve replacement.
Topics: Analgesics, Opioid; Aortic Valve; Blood Pressure; Cardiac Output; Cardiopulmonary Bypass; Catheters, Indwelling; Creatine Kinase, MB Form; Female; Heart Rate; Heart Valve Prosthesis Implantation; Humans; Length of Stay; Male; Middle Aged; Mitral Valve; Myocardial Reperfusion Injury; Prospective Studies; Sodium Chloride; Sufentanil; Troponin I | 2014 |
7 other study(ies) available for sufentanil and Injury, Myocardial Reperfusion
| Article | Year |
|---|---|
Protective Effect of Sufentanil on Myocardial Ischemia-Reperfusion Injury in Rats by Inhibiting Endoplasmic Reticulum Stress.
Topics: Animals; Endoplasmic Reticulum Stress; Humans; Male; Malondialdehyde; Myocardial Reperfusion Injury; Myocardium; Rats; Sufentanil | 2022 |
Sufentanil preconditioning protects against myocardial ischemia/reperfusion injury via miR-125a/DRAM2 axis.
Topics: Animals; Cardiotonic Agents; Cell Line, Transformed; Ischemic Preconditioning, Myocardial; Male; Membrane Proteins; MicroRNAs; Myocardial Reperfusion Injury; Myocytes, Cardiac; Rats; Rats, Sprague-Dawley; Sufentanil | 2021 |
The effect of intrathecal sufentanil preconditioning against myocardial ischemia-reperfusion injury.
Topics: Analgesics, Opioid; Animals; Arterial Pressure; Blood Pressure; Cardiotonic Agents; Electrocardiography; Heart; Heart Rate; Injections, Spinal; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Rabbits; Sufentanil | 2018 |
[Effect of sufentanil preconditioning on myocardial P-Akt expression in rats during myocardial ischemia-reperfusion].
Topics: Animals; Ischemic Preconditioning, Myocardial; Male; Myocardial Reperfusion Injury; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction; Sufentanil | 2014 |
Long-term insulin treatment restores cardioprotection induced by sufentanil postconditioning in diabetic rat heart.
Topics: Animals; Cardiotonic Agents; Cardiovascular Diseases; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Disease Models, Animal; Hypoglycemic Agents; Insulin; Ischemic Postconditioning; Male; Myocardial Reperfusion Injury; Rats, Sprague-Dawley; Sufentanil; Treatment Outcome | 2016 |
Sufentanil limits the myocardial infarct size by preservation of the phosphorylated connexin 43.
Topics: Animals; Cardiotonic Agents; Connexin 43; Ischemic Postconditioning; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Phosphorylation; Rats; Rats, Sprague-Dawley; Sufentanil | 2012 |
Sufentanil postconditioning protects the myocardium from ischemia-reperfusion via PI3K/Akt-GSK-3β pathway.
Topics: Animals; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Hemodynamics; Ischemic Postconditioning; Male; Myocardial Reperfusion Injury; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Sufentanil | 2012 |